Johnson & Johnson announced that it plans to make a billion coronavirus vaccines for next year. The sayings were announced by Paul Stoffels, the company’s chief scientist in a conversation with ABC. “We’re going to start clinical testing in September and hope to have the data by the end of the year,” he explained.
Dr. Paul Stoffels, Johnson & Johnson chief scientific officer, says COVID-19 is spreading “so fast” around the world and it won’t pass without a vaccine. Clinical trials begin in September with “the aim to deliver 1 billion vaccines next year,” he adds. https://t.co/4JsbbNCold pic.twitter.com/ORaIb2uXQB— ABC News (@ABC)
May 10, 2020
As Stoffels said, Johnson & Johnson is already working to increase production and will begin manufacturing the vaccine earlier this year. “We’re going to have a vaccine available later this year, but it will be up to the authorities to decide whether it can be used before the efficacy data become available,” he said.
From a doctor who survived Ebola and is now treating #COVID19 patients to a #JNJ scientist leading work on a potential vaccine candidate, episode 4 of “The Road to a Vaccine” provided an inside look at the people working toward solutions for COVID-19. Watch to learn more. pic.twitter.com/mIxys50orJ — Johnson & Johnson (@JNJNews)
May 10, 2020
The brand explained that the process of developing a vaccine takes five to seven years, but admitted that, because of the pandemic, the time frame has been substantially accelerated to find the vaccine.
